- · 《国际精神病学杂志》栏[06/30]
- · 《国际精神病学杂志》收[06/30]
- · 《国际精神病学杂志》投[06/30]
- · 《国际精神病学杂志》征[06/30]
- · 《国际精神病学杂志》刊[06/30]
一、本刊要求作者有严谨的学风和朴实的文风，提倡互相尊重和自由讨论。凡采用他人学说，必须加注说明。 二、不要超过10000字为宜，精粹的短篇，尤为欢迎。 三、请作者将稿件（用WORD格式）发送到下面给出的征文信箱中。 四、凡来稿请作者自留底稿，恕不退稿。 五、为规范排版，请作者在上传修改稿时严格按以下要求： 1．论文要求有题名、摘要、关键词、作者姓名、作者工作单位（名称，省市邮编）等内容一份。 2．基金项目和作者简介按下列格式： 基金项目：项目名称（编号） 作者简介：姓名（出生年－），性别，民族（汉族可省略），籍贯，职称，学位，研究方向。 3．文章一般有引言部分和正文部分，正文部分用阿拉伯数字分级编号法，一般用两级。插图下方应注明图序和图名。表格应采用三线表，表格上方应注明表序和表名。 4．参考文献列出的一般应限于作者直接阅读过的、最主要的、发表在正式出版物上的文献。其他相关注释可用脚注在当页标注。参考文献的著录应执行国家标准GB7714-87的规定，采用顺序编码制。
中国精神病临床高危综合征早期识别和干预精神(6)
作者:网站采编关键词:
摘要：[28]AMMINGER GP,SCHAFER MR,PAPAGEORGIOU K,et omega-3 fatty acids for indicated prevention of psychotic disorders：a randomized,placebo-controlled trial[J].Arch Gen Psychiatry,2010,67(2)：146-154. [2
[28]AMMINGER GP,SCHAFER MR,PAPAGEORGIOU K,et omega-3 fatty acids for indicated prevention of psychotic disorders：a randomized,placebo-controlled trial[J].Arch Gen Psychiatry,2010,67(2)：146-154.
[29]MCGORRY PD,NELSON B,MARKULEV C,et of omega-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders：The NEURAPRO Randomized Clinical Trial[J].JAMA Psychiatry,2017,74(1)：19-27.
[30]AMMINGER GP,NELSON B,MARKULEV C,et al.The NEURAPRO Biomarker Analysis：Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis[J].Biol Psychiatry,2020,87(3)：243-252.
[31]MCGORRY PD,YUNG AR,PHILLIPS LJ,et controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms[J].Arch Gen Psychiatry,2002,59(10)：921-928.
[32]WOODS SW,BREIER A,ZIPURSKY RB,et trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome[J].Biol Psychiatry,2003,54(4)：453-464.
[33]MCGLASHAN TH,ZIPURSKY RB,PERKINS D,et ,double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis[J].Am J Psychiatry,2006,163(5)：790-799.
[34]YUNG AR,PHILLIPS LJ,NELSON B,et controlled trial of interventions for young people at ultra high risk for psychosis：6-month analysis[J].J Clin Psychiatry,2011,72(4)：430-440.
[35]CANNON TD,YU C,ADDINGTON J,et al.An Individualized Risk Calculator for Research in Prodromal Psychosis[J].Am J Psychiatry,2016,173(10)：980-988.
[36]ZHANG T,XU L,LI H,et individualized risk components using a mobile app-based risk calculator for clinical high risk of psychosis：findings from ShangHai At Risk for Psychosis(SHARP)program[J].Psychol Med,2019(2019-12-16)[2020-04-27].http：///10.1017/S360X.
[37]COLLIN G,SEIDMAN LJ,KESHAVAN MS,et connectome organization predicts conversion to psychosis in clinical high-risk youth from the SHARP program[J].Mol Psychiatry,2018(2018-11-08)[2020-04-27].http：///10.1038/s-018-0288-x.
[38]LI Z,ZHANG T,XU L,et risk of psychosis by sulforaphane study protocol for a randomized,double-blind,placebo-controlled,clinical multicenter trial[J].Early Interv Psychiatry,：///10.1111/eip..
[39]WU G,GAN R,LI Z,et Effectiveness and Safety of Antipsychotics in Individuals at Clinical High-Risk for Psychosis：Study Protocol for a Prospective Observational Study(ShangHai at Risk for Psychosis-Phase 2)[J].Neuropsychiatr Dis Treat,2019,15：3541-3548.
文章来源：《国际精神病学杂志》 网址: http://www.gjjsbxzz.cn/qikandaodu/2021/0226/601.html
上一篇：中国神经精神疾病杂志简介
下一篇：人格诊断问卷在军人群体中的应用